As of the latest Form 4 filed Jul 9, 2026.
What Elanco Animal Health insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 38 most recent filings for ELAN.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | 2026-07-07 | VanHimbergen Robert M EVP and CFO | FTax | −15.3K | $24.64 | $378K | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Ma Stacey Director | AAward | +12.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Ma Stacey, Director | AAward | +4.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Anand Kapila K Director | AAward | +12.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Anand Kapila K, Director | AAward | +4.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Harrington Michael J Director | AAward | +12.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Harrington Michael J, Director | AAward | +4.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | McDonald Kirk P Director | AAward | +12.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | McDonald Kirk P, Director | AAward | +4.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Kochevar Deborah Turner Director | AAward | +4.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Herendeen Paul Director | AAward | +12.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Herendeen Paul, Director | AAward | +4.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Kurzius Lawrence Erik Director | AAward | +12.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Kurzius Lawrence Erik, Director | AAward | +4.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Scots-Knight Denise Director | AAward | +12.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | Scots-Knight Denise, Director | AAward | +4.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | HOOVER R DAVID Director | AAward | +4.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | GARCIA ART A Director | AAward | +12.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-26 | 2026-05-21 | GARCIA ART A, Director | AAward | +4.68K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | Modi Rajeev A. SEE REMARKS | PPurchase | +4.91K | $20.35 | $99.9K | No | Form 4 ↗ |
| 2026-05-19 | 2026-05-15 | Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR | PPurchase | +4.97K | $20.09 | $99.8K | No | Form 4 ↗ |
| 2026-04-07 | 2026-04-01 | de Brabander Ellen SEE REMARKS | FTax | −20.3K | $23.12 | $469K | No | Form 4 ↗ |
| 2026-04-07 | 2026-04-01 | de Brabander Ellen, SEE REMARKS | AAward | +41.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | O'Neill Shiv GC AND CORP SEC | FTax | −4.74K | $24.88 | $118K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | McArdle Grace EVP, MANUFACTURING AND QUALITY | FTax | −4.32K | $24.88 | $108K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Modi Rajeev A. SEE REMARKS | FTax | −4.39K | $24.88 | $109K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | de Brabander Ellen SEE REMARKS | FTax | −8.26K | $24.88 | $206K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Correia de Simas Jose Manuel SEE REMARKS | FTax | −3.37K | $24.88 | $83.9K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Bettington Timothy J SEE REMARKS | FTax | −4.70K | $24.88 | $117K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Meer James M CHIEF ACCOUNTING OFFICER | FTax | −1.39K | $24.88 | $34.6K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Kinard David S SEE REMARKS | FTax | −3.43K | $24.88 | $85.4K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Cabral Ramiro Martin SEE REMARKS | FTax | −6.49K | $24.88 | $162K | No | Form 4 ↗ |
| 2026-03-05 | 2026-03-03 | Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR | FTax | −37.9K | $24.88 | $943K | No | Form 4 ↗ |
| 2025-12-23 | 2025-12-19 | HOOVER R DAVID Director | GGift | −60.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2025-12-16 | 2025-12-12 | Kurzius Lawrence Erik Director | PPurchase | +10.0K | $21.30 | $213K | No | Form 4 ↗ |
| 2025-12-15 | 2025-12-11 | Modi Rajeev A. SEE REMARKS | PPurchase | +4.50K | $21.33 | $96.0K | No | Form 4 ↗ |
| 2025-12-15 | 2025-12-11 | VanHimbergen Robert M EVP and CFO | PPurchase | +6.95K | $21.64 | $150K | No | Form 4 ↗ |
| 2025-12-15 | 2025-12-11 | Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR | PPurchase | +22.0K | $21.75 | $478K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ELAN’s full analysis or the market-wide insider trading feed. The tabs above jump to ELAN’s other SEC data.
Source: SEC Form 4 filings for ELAN, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.